|
16 Nov 2020 |
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
|
|
12 Nov 2020 |
MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
|
|
09 Nov 2020 |
Infinity Pharmaceuticals Presents New MARIO-1 Phase 1/1b Clinical Data at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
|
|
06 Nov 2020 |
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
|
|
06 Nov 2020 |
Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies
|
|
06 Nov 2020 |
Novo Nordisk to acquire Emisphere Technologies and obtain ownership of the Eligen® SNAC oral delivery technology
|
|
05 Nov 2020 |
Merck to Acquire VelosBio
|
|
03 Nov 2020 |
Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination Therapies
|
|
02 Nov 2020 |
Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance Therapeutic Development
|
|
02 Nov 2020 |
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
|
|
29 Oct 2020 |
Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
|
|
28 Oct 2020 |
insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
|
|
26 Oct 2020 |
AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration
|
|
23 Oct 2020 |
Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital Business
|
|
23 Oct 2020 |
Retrophin Announces Agreement to Acquire Orphan Technologies
|
|
19 Oct 2020 |
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
|
|
19 Oct 2020 |
Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™
|
|
17 Oct 2020 |
Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV Platform at Virtual R&D Day Today
|
|
16 Oct 2020 |
XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation Technology
|
|
15 Oct 2020 |
Lilly Announces Agreement to Acquire Disarm Therapeutics
|
|
14 Oct 2020 |
Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic
|
|
14 Oct 2020 |
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
|
|
14 Oct 2020 |
Secarna Pharmaceuticals and Denali Therapeutics Enter Into Research and Option Agreement to Develop Novel Antisense Therapies in the Field of Neurodegenerative Diseases
|
|
13 Oct 2020 |
Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies
|
|
12 Oct 2020 |
HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery
|
